Bactolife A/s
Clinical trials sponsored by Bactolife A/s, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a stool test predict c. Diff's return? Results expected Oct 2026 (estimated)
- New food ingredient BP-CBB put to the test in first human study Results expected Dec 2026 (estimated)
- Gut-Acting protein BP-LT put to the test for safety Results expected Mar 2027 (estimated)
- Can a Gut-Targeted protein pass the safety test? Results expected Sep 2027 (estimated)
-
Gut-Acting protein BP-LT put to the test for safety
Prevention Not yet recruitingResearchers are testing whether a food ingredient called BP-LT is safe and well tolerated when added to a daily diet. BP-LT is a stable protein that works in the gastrointestinal tract without being absorbed into the body. The trial enrolls healthy adults first, then healthy chil…
Sponsor: Bactolife A/S • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can a Gut-Targeted protein pass the safety test?
Knowledge-focused Not yet recruitingResearchers are testing whether a food ingredient called IgG Binding Protein LT is safe and well tolerated when healthy adults take it twice a day for three weeks. The protein is designed to act in the gut without being absorbed into the body. Forty healthy volunteers aged 18 to …
Sponsor: Bactolife A/S • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC